This job has expired

You will need to login before you can apply for a job.

Senior Scientist/Principal Scientist in the Molecular Interactions Group

Coherus BioSciences
Camarillo, California
Start date
Aug 8, 2022

View more

Science/R&D, Biotechnology
Required Education
Position Type
Full time
You need to sign in or create an account to save a job.

Job Details

Title:                          Senior Scientist/Principal Scientist in the Molecular Interactions Group
Reports To:               
Senior Scientific Research Fellow
:                   Camarillo, California
Classification:          Exempt 



The qualified individual will join the Molecular Interactions Group in the Translational and Development Sciences Department at Coherus in Camarillo, CA, and aid in the advancement of Coherus’ pipeline. The individual required for this position must have rigorous physicochemical skills as they relate to biophysical characterization of protein/protein interactions.  The selected scientist must have deep knowledge in both theoretical and practical aspects of ligand-macromolecule kinetic and binding concepts based on chemical principles.  Hands-on experience and a solid understanding of surface plasmon resonance biosensors is required. Demonstrated ability to train and interact with scientists at various levels in diverse scientific teams is also required. In addition, an unparalleled work ethic with tremendous motivation to drive assigned projects to a sound scientific conclusion is required.

The position requires the candidate to be a critical thinker, researcher, and self-starter in assay design and development. The incumbent will conduct method development and analyze samples to support an immuno-oncology product pipeline. The candidate should be detail oriented in execution and will perform experiments on the bench at an advanced level. The candidate is also expected to be able to design independently biophysical experiments that are cutting-edge. The candidate will be required to summarize and present their data to internal cross-functional teams and possibly at external meetings.  The candidate is required to be competent in writing scientific reports at the level that would be expected to publish in a professional scientific journal.


  • PhD in Physical Biochemistry, Biophysics, Analytical Biochemistry, or Analytical/Physical Chemistry with a minimum of 8-12 years academic research or industry experience
  • Capable of performing and analyzing kinetic and thermodynamic studies of protein/protein interactions using state of the art biosensors
  • Proficient in statistical tools to critically analyze data
  • Excellent record keeping abilities to adequately record, analyze, and document analytical data generated in support of a research pipeline
  • Experienced in preparation and characterization of critical reagents and strong data analysis skills
  • Ability to handle multiple projects, demonstrate initiative, strong attention to detail, with effective verbal and written communication skills
  • Maintains effective communication with line management
  • Ability to work independently as well as in a team; trusts and respects team
  • Candidate must be highly motivated and able to work in a fast-paced environment

Beginning July 19, 2021, Coherus BioSciences requires all new hires to be fully vaccinated against COVID-19 as of their start date.  This requirement is a condition of employment at Coherus BioSciences, and it applies regardless of whether the position is located at a Coherus BioSciences facility or is fully remote.  If you are unable to receive the vaccine due to a disability or serious medical condition, or because it is prohibited as a result of your sincerely held religious beliefs, you will have an opportunity to request a reasonable accommodation. 


We are committed to making high-value biosimilars affordable for everyone. It’s an unconventional approach to business that defines who we are and what we do.

At Coherus, we hold ourselves to a higher standard. We don’t break the rules—we write our own.

In early 2021, we expanded our mission into immuno-oncology with a collaboration with Shanghai Junshi Biosciences for the development and commercialization of toripalimab, Junshi Biosciences’ novel anti-PD-1 antibody, in the United States and Canada.

We are embarking on a new phase in our evolution, focused on expanding patient access to important, cost-effective medicines and delivering significant savings to the U.S. healthcare system. Join us, as we seek to break down barriers and make a difference in patients’ lives.

Stock Symbol: CHRS

Stock Exchange: NASDAQ

Find Us
333 Twin Dolphin Dr, #600
Redwood City
United States
You need to sign in or create an account to save a job.

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert